Monday, 6 July 2020

Reuters Health Report: Regeneron begins COVID-19 antibody cocktail late-stage trial

Reuters.com Newsletter

Regeneron begins COVID-19 antibody cocktail late-stage trial

Regeneron Pharmaceuticals Inc said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating COVID-19.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

Spanish antibody study shows 5% of population exposed to coronavirus

Results from the final stage of a nationwide antibody study showed some 5.2% of Spain's population has been exposed to the coronavirus, health officials said on Monday, confirming findings from earlier stages.

U.S. regulator greenlights Becton Dickinson's rapid antigen test for COVID-19

The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to Becton Dickinson and Co for a COVID-19 antigen test that can be administered at the point of care and produce results within 15 minutes, the company said on Monday.

Make a vaccine? I'm trying to teach my kids the alphabet

It's tough to do any useful work when you're stuck at home, struggling to home-school bickering kids, let alone when you're trying to produce a COVID-19 vaccine.

With nearly 700,000 coronavirus cases, India is third worst-hit country

India has over-taken Russia with the world's third-highest number of novel coronavirus cases, at nearly 700,000, according to the latest data, as the outbreak shows no sign of slowing.

Hundreds of scientists say coronavirus is airborne, ask WHO to revise recommendations: NYT

Hundreds of scientists say there is evidence that the novel coronavirus in smaller particles in the air can infect people and are calling for the World Health Organization to revise recommendations, the New York Times reported on Saturday.

Emergent to make drug substance for J&J's COVID-19 vaccine candidate

Emergent BioSolutions Inc said on Monday it has signed a five-year pact to make the drug substance used in Johnson & Johnson's COVID-19 vaccine candidate, in a deal valued at about $480 million for the first two years.

CureVac nets EU funding to ramp up vaccine production

German biotech company CureVac, which is developing a potential COVID-19 vaccine, has secured a 75 million euro ($85 million) loan from the European Investment Bank to boost its manufacturing capacity.

Australia closes state border for first time in 100 years after COVID-19 spike

The border between Australia's two most populous states will close from Tuesday for an indefinite period as authorities scramble to contain an outbreak of the coronavirus in the city of Melbourne.

Soaring U.S. coronavirus cases, hospitalizations overshadow July 4 celebrations

Rising coronavirus cases in 39 U.S. states cast a shadow over the nation's Fourth of July celebrations as health experts worried that holiday parties will cause a further spike in infections that could overwhelm hospitals.

Related Videos

'Hamilton' goes from Broadway to America's living rooms

Remembering comedy icon Carl Reiner, dead at 98

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS